Inc. (STI) is an early stage small biotech company engaged in the development of therapies for infertility patients. STI is
initially focused in repositioning existing approved pharmaceutical products in new infertility indications.
Our lead product candidate STI2832 is indicated for treating a condition caused by a fertility
drug. Steptoe Therapeutics is preparing for a pre-IND meeting with the FDA to discuss the development of STI2832.
The company has recently secured intellectual property for the use of a cytokine in ovulation induction (US Patent
Steptoe Therapeutics Inc. is based in Hingham, Massachussetts 20 miles south
of Boston. The company is small developing it's product candidates with private funding using a very small footprint
STI associated company BMT Management, LLC has been distributing medical
products and equipment in reproductive medicine since 2003. The company is operating as Steptoe Medical Devices in the